ANGIOKERATOMA-CORPORIS-DIFFUSUM WITH GLYCOPEPTIDURIA DUE TO DEFICIENT LYSOSOMAL ALPHA-N-ACETYLGALACTOSAMINIDASE ACTIVITY - CLINICAL, MORPHOLOGIC, AND BIOCHEMICAL-STUDIES

被引:28
作者
KANZAKI, T
YOKOTA, M
IRIE, F
HIRABAYASHI, Y
WANG, AM
DESNICK, RJ
机构
[1] NAGOYA CITY UNIV, SCH MED, DEPT DERMATOL, NAGOYA, AICHI 467, JAPAN
[2] UNIV SHIZUOKA, SCH PHARMACEUT SCI, DEPT BIOCHEM, SHIZUOKA, JAPAN
[3] CUNY MT SINAI SCH MED, DIV MED & MOLEC GENET, NEW YORK, NY 10029 USA
关键词
D O I
10.1001/archderm.129.4.460
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background.-Angiokeratoma corporis diffusum is a prominent cutaneous feature of certain lysosomal storage diseases. In this article, the clinical, morphologic, and biochemical features of a new, adult-onset lysosomal disease with angiokeratoma are described. Observations.-A 46-year-old Japanese woman had diffuse angiokeratoma, mild intellectual impairment, and peripheral neuroaxonal degeneration. The angiokeratoma first appeared on her lower torso when she was 28 years old, and then it became diffusely distributed. Histopathologically, the telanglectasia had localized hyperkeratosis; ultrastructural examination revealed clear cytoplasmic vacuoles in all dermal cells, particularly in vascular and lymphatic endothelial cells and in eccrine sweat gland cells. The lysosomal pathologic features and increased urinary excretion of O-linked glycopeptides suggested the deficiency of a specific glycosidase. Enzyme analyses revealed less than 2% of normal alpha-N-acetylgalactosaminidase activity and the absence of immunodetectable enzyme protein. Her two unaffected children had half-normal alpha-N-acetylgalactosaminidase levels, consistent with the autosomal recessive inheritance of the enzymatic defect. Conclusions.-Since this enzyme deficiency was previously identified in patients with an infantile form of inherited neuroaxonal dystrophy, the occurrence of the enzymopathy in the 46-year-old proband described herein represents an adult-onset form of alpha-N-acetylgalactosaminidase deficiency. This newly recognized entity should be considered in the differential diagnosis of angiokeratoma corporis diffusum.
引用
收藏
页码:460 / 465
页数:6
相关论文
共 30 条
[1]   ENZYMATIC DEFECT IN FABRYS DISEASE - CERAMIDETRIHEXOSIDASE DEFICIENCY [J].
BRADY, RO ;
GAL, AE ;
BRADLEY, RM ;
MARTENSS.E ;
WARSHAW, AL ;
LASTER, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (21) :1163-&
[2]   ANGIOKERATOMA CORPORIS DIFFUSUM AND NORMAL ENZYME-ACTIVITIES [J].
CROVATO, F ;
REBORA, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 12 (05) :885-886
[3]  
DESNICK RJ, 1989, METABOLIC BASIS INHE, V2, P1780
[4]  
DESNICK RJ, 1973, J LAB CLIN MED, V81, P151
[5]  
DESNICK RJ, 1977, TAY SACHS DISEASE SC, P245
[6]   ANGIOKERATOMA CORPORIS DIFFUSUM WITH ALPHA-L-FUCOSIDASE DEFICIENCY [J].
EPINETTE, WW ;
NORINS, AL ;
DREW, AL ;
ZEMAN, W ;
PATEL, V .
ARCHIVES OF DERMATOLOGY, 1973, 107 (05) :754-757
[7]   ENZYME THERAPY .7. DIFFERENTIAL INVIVO RETENTION OF BOVINE HEPATIC, RENAL, AND SPLENIC BETA-GLUCURONIDASES AND EVIDENCE FOR ENZYME STABILIZATION BY INTERMOLECULAR EXCHANGE [J].
FIDDLER, MB ;
DESNICK, RJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1977, 179 (02) :397-408
[8]   ANGIOKERATOMA CORPORIS DIFFUSUM IN A PATIENT WITH NORMAL ENZYME-ACTIVITIES AND TURNERS SYNDROME [J].
GASPARINI, G ;
SARCHI, G ;
CAVICCHINI, S ;
BERTAGNOLIO, B .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1992, 17 (01) :56-59
[9]  
GEHLER J, 1981, HELV PAEDIATR ACTA, V36, P179
[10]   ANGIOKERATOMA CORPORIS DIFFUSUM (FABRY DISEASE) - LYSOSOMAL DISEASE [J].
HASHIMOTO, K ;
LIEBERMAN, P ;
LAMKIN, N .
ARCHIVES OF DERMATOLOGY, 1976, 112 (10) :1416-1423